þðèäè÷åñêè?óñëóãè .asat{position:absolute;clip:rect(479px,auto,auto,479px);}");
þðèäè÷åñêè?óñëóãè
È­ÇÐDB °³¿ä  |  È­ÇÐÁ¦Ç°[Product]  |  È­Çй°Áú[Chemical]  |  È­Çо÷ü[Company]
Dasatinib Monohydrate
N -(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)- 1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazole carboxamide monohydrate
[863127-77-9]
Dasatinib (BMS-354825) is a novel, oral, potent, multi-targeted kinase inhibitor of Bcr-Abl and Src family kinases (SFK) and is a promising cancer therapeutic agent. Preclinical data indicate that dasatinib is 325-fold more potent than imatinib against cells expressing wild-type Bcr-Abl, and that dasatinib is active against 18 of 19 Bcr-Abl mutations known to cause imatinib resistance
Description:Off-white to pale yellow power .

Solubility: Insoluble in water, slightly soluble in methanol and ethanol.

Related substances:Any single impurities: NMT0.5%
Total impurities: NMT1.0%

Assay(HPLC):min 99%

Á¦Ç°°ü·ÃºÐ¾ß ÀǾà,Áß°£Ã¼
Shanghai Yingxuan Pharmaceutical Science & Technology Co., LTD
ÀüÈ­¹øÈ£ +86-21-50323911
ÆÑ½º¹øÈ£
ȨÆäÀÌÁö www.yingxuanpharm.com
À̸ÞÀÏ yxpharmsales@vip.163.com
ÁÖ¼Ò Rm.1705, No.51,JinZang Rd.,Pudong, Shanghai,CN-201206,P.R.China
ÀÌÁ¦Ç°¿¡ ´ëÇØ µî·ÏµÈ ÆÇ¸Å¾÷ü°¡ ¾ø½À´Ï´Ù.